Risankizumab�用于治疗牛皮癣,特别是严重成人患者斑块性银屑病。
Risankizumab�用于治疗牛皮癣特别是严重成人患者斑块性银屑病。牛皮癣�是一种皮肤病,有红、发痒有鳞的补丁在膝盖,手肘,躯干和头皮,�
过敏症,Risankizumab
它可以注入:75在每个单剂量肾上腺素0.83毫克/毫升注射器。推荐的初始剂量为150毫克(两个75毫克注射)在0周,星期4,每12周之后。
牛皮癣是一种免疫疾病以来,Risankizumab应采取在很长一段时间的指令下医生,每个人都应该经常访问医生,以确保药物的安全性。
Risankizumab是由皮下(注入皮肤的脂肪层)的路线。病人可能self-inject。
在错失了一个剂量的情况下,管理尽快剂量。此后,简历在常规剂量预定时间后训练。
1。Respiratory system: Respiratory tract infections, sinusitis, rhinitis (running nose), nasopharyngitis, pharyngitis, tonsillitis
2。Central nervous system: Tension headache, sinus headache.
3所示。General: Fatigue, injection site pain, redness, leakage of blood, infection, swelling, pruritus (itching) etc.
1。Risankizumab may increase the chance of infections. If an infection develops, do not start Risankizumab until the infection resolves.
2。Evaluate patients for tuberculosis before initiating treatment with Risankizumab.
3所示。一个void administration of live vaccines during the treatment with Risankizumab.
4所示。Patients who are pregnant, lactating should consult health care provider before starting the therapy.
5。Elder patients aged above 75 years and adolescents below 18 years should consult health care provider before starting the therapy.
Risankizumab将与活疫苗。
存储在冰箱里2到8��C C之间。
不冻结或震动,保护箱。